↓ Skip to main content

Cardiometabolic Effects of Empagliflozin in Patients Undergoing Elective Percu-taneous Coronary Intervention for Type 2 Diabetes Mellitus.

Overview of attention for article published in Kardiologiia, December 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiometabolic Effects of Empagliflozin in Patients Undergoing Elective Percu-taneous Coronary Intervention for Type 2 Diabetes Mellitus.
Published in
Kardiologiia, December 2022
DOI 10.18087/cardio.2022.12.n1838
Pubmed ID
Authors

V. N. Karetnikova, A. A. Kchorlampenko, A. M. Kochergina, A. V. Osokina, O. V. Gruzdeva, D. P. Golubovskaia, O. L. Barbarash

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.